Revolutionary medical treatments offer new hope for chronic pain sufferers through advanced technology, targeted medications ...

Introducing Journavx: the FDA-approved non-opioid, non-addictive drug for acute pain. A major breakthrough in pain medication ...

The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...

FDA Approves Non-Opioid Treatment for Moderate to Severe Acute Pain as Agency Continues to Take Steps to Support New ...

The FDA's approval of the non-addictive painkiller Journavx last week marked a milestone in the field of pain management. Why ...

Experts with the Cleveland Clinic say the drug has a lot of potential, especially since it is considered nonaddictive.

Critical assessment of evidence to help you make decisions. Advice, rather than formal NICE guidance.

Suzetrigine selectively inhibits the NaV1.8 pain-signaling pathway in the peripheral nervous system and provides effective ...

On Wednesday, the U.S. Food and Drug Administration approved a new pain management drug which could change the way healthcare ...

Acupuncturist believe our bodies have pathways of vital energy. When energy gets blocked, it can cause pain. Inserting needles along the pathways eases the pain, they say. If you want to give dry ...

Vertex has gained the FDA's approval for its nonaddictive pain med Journavx, which becomes the first significant innovation ...